Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin’s lymphoma - Hashino, S; Morioka, M; Irie, T (Int J Lab Hematol, 2008)
et al.